What are the most commonly used Angiotensin-Converting Enzyme (ACE) inhibitors, including their brand and generic names?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Commonly Used ACE Inhibitors with Brand and Generic Names

The most commonly used ACE inhibitors include lisinopril (Prinivil, Zestril), enalapril (Vasotec), ramipril (Altace), and captopril (Capoten), which are widely prescribed for hypertension, heart failure, and diabetic nephropathy. 1

Comprehensive List of ACE Inhibitors

First-Line/Most Commonly Used ACE Inhibitors

  • Lisinopril

    • Brand names: Prinivil, Zestril
    • Dosing: 10-40 mg once daily
    • Notable features: Does not require hepatic activation, linear dose-response relationship 1, 2
  • Enalapril

    • Brand name: Vasotec
    • Dosing: 5-40 mg daily in 1-2 divided doses
    • Notable features: Prodrug requiring hepatic activation 1
  • Ramipril

    • Brand name: Altace
    • Dosing: 1.25-20 mg daily in 1-2 divided doses
    • Notable features: Reduced mortality in post-MI patients 1, 2
  • Captopril

    • Brand name: Capoten
    • Dosing: 6.25-50 mg three times daily
    • Notable features: First ACE inhibitor developed, shortest half-life (1 hour) 1, 3

Other Commonly Used ACE Inhibitors

  • Benazepril

    • Brand name: Lotensin
    • Dosing: 10-40 mg daily in 1-2 divided doses 1
  • Fosinopril

    • Brand name: Monopril
    • Dosing: 10-80 mg daily
    • Notable features: Dual elimination (renal and hepatic) 1, 3
  • Quinapril

    • Brand name: Accupril
    • Dosing: 10-80 mg daily in 1-2 divided doses 1
  • Perindopril

    • Brand name: Aceon
    • Dosing: 4-16 mg daily in 1-2 divided doses 1
  • Trandolapril

    • Brand name: Mavik
    • Dosing: 1-4 mg daily
    • Notable features: Long half-life, good trough-to-peak ratio 1, 4
  • Moexipril

    • Brand name: Univasc
    • Dosing: 7.5-30 mg daily in 1-2 divided doses
    • Notable features: Should be taken 1 hour before meals 1, 4

Clinical Considerations

Pharmacokinetic Differences

  • Half-life variations: Range from 1 hour (captopril) to over 24 hours (trandolapril) 3
  • Bioavailability: Varies widely from 11% (trandolapril) to >60% (captopril) 3
  • Elimination routes: Most are primarily eliminated through kidneys, but benazepril, fosinopril, ramipril, and trandolapril also have significant hepatic elimination 3

Important Adverse Effects

  • Cough: Occurs in up to 20% of patients, more common in women and Asian patients 1
  • Angioedema: Occurs in <1% of patients but more frequent in Black patients; requires permanent discontinuation of all ACE inhibitors 1
  • Hyperkalemia: Especially in patients with renal impairment or those taking potassium-sparing diuretics 1
  • Acute renal failure: More common in patients with bilateral renal artery stenosis, volume depletion, or heart failure 1

Dosing Considerations

  • Renal impairment: Dose adjustment required for most ACE inhibitors when creatinine clearance is <30 mL/min 3
  • Heart failure: Start with low doses and titrate gradually 1
  • Elderly patients: Consider starting at lower doses 4

ACE inhibitors remain first-line agents for hypertension, heart failure, and diabetic nephropathy due to their proven mortality benefits and generally favorable side effect profile compared to other antihypertensive classes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

ACE Inhibitors in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Comparative evaluation of ACE inhibitors: which differences are relevant?].

Schweizerische medizinische Wochenschrift, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.